Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JJGC Indústria e Comércio de Materiais Dentários, operating under the brand name Neodent, is a global leader in the design and manufacture of dental implants and prosthetic solutions. Founded in 1993 by Dr. Geninho Thomé, the company is headquartered in Curitiba, Brazil, and has grown to become the second-largest dental implant company in the world. Neodent specializes in providing accessible, high-quality oral rehabilitation products, including its flagship Grand Morse implant system and various digital dentistry tools. The company's portfolio encompasses a wide range of titanium and ceramic implants, abutments, and surgical kits designed to simplify clinical workflows. In 2015, Neodent was fully acquired by the Straumann Group, which facilitated its expansion into more than 60 international markets. Today, the company maintains a strong focus on research and development to advance immediate loading protocols and improve patient outcomes in restorative dentistry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JJGC Industria e Comercio de Materiais Dentarios.